Kenya launches $180 million AIDS plan:
This article was originally published in Clinica
Executive Summary
Kenya has launched a $180 million five-year programme to tackle the HIV/AIDS epidemic that is now responsible for an estimated 600 deaths a day. Although firm plans have yet to be drawn up, the government has pledged to expand clinical services, including the construction of an HIV testing centre in Nairobi. Japan, the UK, the US, Germany and the World Bank have recently announced new funding for this and other health programmes in Kenya, Africa Health reports. The epidemic is said to be costing the economy around $2.7 million per day. Meanwhile, Kenya's health ministry is investigating the potential inaccuracy of test results, following recent inconsistencies in prevalence data reported in parts of the country.
You may also be interested in...
US Q1 Consumer Health Earnings Preview: Label This One Historic And Challenging But Promising
US OTC drug and supplement firms’ reports of results for the first three months of 2024 began on April 19 with P&G. JP Morgan analysts say while “some retailers in the US in particular” are reducing consumer health inventories, for the overall sector they expect “a healthier balance of positive volume and lower pricing contribution.”
Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa
The US FDA’s approval of Lumicell’s optical imaging agent Lumisight makes a dozen novel approvals in 2024 for the Center for Drug Evaluation and Research.
Partisan Politics Returns To US FDA Congressional Oversight
The US FDA has stood out as an agency that tends to draw broad bipartisan support amid a generally rancorous and divided Congress. A House hearing, however, may be a sign that those days are over.